Zamaporvint

N/A

Report date: 2024/05/17 10:16:16
NME

Base Information

Drug NameZamaporvint
Drug Alias NamePorcupine inhibitor(Redx Pharma)RXC-004REDX-06109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-serine O-palmitoleoyltransferase porcupine inhibitorsWnt signalling pathway inhibitors
TargetsProtein-serine O-palmitoleoyltransferase porcupine
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsColorectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRedx Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRedx Pharma Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A